RankingsPricing
  1. US-listed companies
  2. TITAN PHARMACEUTICALS INC

TITAN PHARMACEUTICALS INCTTNP

Market cap
$83.49M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Net loss-15-15----------10
Depreciation and amortization000000000000
Non-cash interest expense------00100-
Non-cash gain on debt extinguishment--2--11-0-01-
Stock-based milestone payment-----------0
Stock-based compensation131111221021
Amortization of restricted stock-----------0
Other--------000-0
Receivables210-10-1-42-1-0-1-0
Inventory--------0-0-0-0-0
Prepaid expenses and other assets1-0-0-000001-0-0-0
Accounts payable2-11-1-0-1-21-01-1-1
Other accrued liabilities-10-0001-100-0-01
Deferred revenue-14-9-4-2-------0
Net cash used in operating activities-142-----13-8-15-17-8-8
Purchases of furniture and equipment01000000010-
Net cash used in investing activities-0-1-----0-0-0-1-0-
Proceeds from equity offerings--------101295
Proceeds from the exercise of warrants--1----327-0
Net cash provided by financing activities1712----711111895
Net change in cash, cash equivalents and restricted cash---------01-3
Right of use asset obtained in exchange for lease liability, net of amortization----------0-